Shikonin, a major effective component in the Chinese herbal medicine Lithospermum erythrorhizon Sieb., exhibits an anti-inflammatory property towards
rheumatoid arthritis (RA), but the potential mechanism is unclear. Our aim was to investigate the mechanism of
shikonin on the
lipopolysaccharide (LPS)-induced fibroblast-like synoviocyte (LiFLS)
inflammation model. Fibroblast-like synoviocytes (FLSs) were treated with 200 μg/ml of LPS for 24 h to establish the RA-like model, LiFLS. FLSs were pretreated with
shikonin (0.1-1 μM) for 30 min in the treatment groups. Quantitative real-time polymerase chain reaction and
enzyme-linked
immunosorbent assays were used to detect
mRNA and
protein levels of
interleukin (IL)-10 and
tumor necrosis factor (TNF)-α. Signal
proteins involved in
IL-10 production were analyzed by Western blotting.
Shikonin significantly reversed the inhibitory effects of LPS on
IL-10 expression in FLSs by inactivating the PKC-NF-κB pathway. In addition,
shikonin inhibited LPS-induced TNF-α expression in FLSs, and this effect was markedly diminished by IL-10-neutralizing antibody. The IL-10-mediated suppression of TNF-α transcription was demonstrated by no response to the
protein synthesis inhibitor cyclohexamide and no mRNA decay.
Shikonin inhibits LPS-induced TNF-α production in FLSs through suppressing the PKC-NF-κB-dependent decrease in
IL-10, and this study also highlights the potential application of
shikonin in the treatment of RA.